Aramis Biotechnologies
↗Quebec City, Canada
Aramis Biotechnologies is a Canadian biotechnology company based in Quebec City, founded in 2023. The company specializes in a next-generation, plant-based biomanufacturing platform that utilizes Nicotiana benthamiana to produce virus-like particles (VLPs) for innovative vaccines.
As a majority employee-owned company, Aramis aims to provide sustainable, scalable, and eco-friendly alternatives to traditional egg-based or cell-culture vaccine manufacturing. Their technology is built upon over two decades of research, including the scientific legacy of Medicago, and is designed to address both current public health needs and future pandemic preparedness.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Vaccine development, Plant-based biomanufacturing
SIZE & FINANCIALS
Employees:51-200
Founded:2023
Ownership:private
Status:operating
FUNDING
Stage:Private
Investors:Private investors
PIPELINE
Stage:Phase 1/2
Lead Drug Stage:Phase 1/2
Modalities:Plant-based VLP (Virus-Like Particle) vaccines
Active Trials:1
Trial Phases:Phase 1: 1 | Phase 2: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Biologics Manufacturing Centre (BMC): Strategic agreement for formulation and finish services., Biodextris: Partnership for downstream manufacturing of clinical materials.
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Frédéric Ors - CEO
Sonia Trépanier - Vice-President, Preclinical and Clinical Development
LINKS
Website:aramisbiotechnologies.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Aramis Biotechnologies and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Aramis Biotechnologies. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.